Egrifta (Tesamorelin)
- HIV/AIDS and Lipodystrophy Treatments Part I: Treatments for Fat Gain (May 2012)
From The Well Project
- Tesamorelin Approved for Lipodystrophy (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Drug Watch: Tesamorelin Update (Summer/Fall 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- New Treatment for Excess Deep Belly Fat Approved (February 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Egrifta Patient Support Information Now Available (January 24, 2011)
In Positively Aware, from Test Positive Aware Network
- Tesamorelin Approved to Reverse Some Fat Gain (December 8, 2010)
Part of "Top HIV/AIDS-Related Clinical Developments of 2010," by David Wohl, M.D.
From TheBody.com
- Fat Busting: But at What Price? (November 12, 2010)
In POZ
- A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy) (November 11, 2010)
An interview with Daniel Berger, M.D.
In This Month in HIV, from TheBody.com
- An Overview of Tesamorelin (November 11, 2010)
From AIDSinfo
- FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV (November 10, 2010)
From U.S. Food and Drug Administration
- FDA Decision on Egrifta (Tesamorelin) Delayed Until Fall: A Blog Entry by Myles Helfand (August 3, 2010)
From TheBody.com
The Power of Advocacy (July/August 2010)
A first-hand account of how testimony helped win an FDA panel's approval of a new drug.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Committee Unanimously Recommends Egrifta for Lipodystrophy (May 27, 2010)
In POZ Magazine
- FDA Staff: Theratech Drug Works, but Risks Weighed (May 26, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Belly Fat Drug Debated Even Before FDA Approval (February 22, 2010)
In Housing Works AIDS Issues Update, from Housing Works
|
Advertisement
|